X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS AUROBINDO PHARMA DR. DATSONS LABS/
AUROBINDO PHARMA
 
P/E (TTM) x -10.9 18.4 - View Chart
P/BV x 0.2 6.0 2.7% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 DR. DATSONS LABS   AUROBINDO PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
AUROBINDO PHARMA
Mar-16
DR. DATSONS LABS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1261,541 8.2%   
Low Rs31582 5.3%   
Sales per share (Unadj.) Rs133.0237.5 56.0%  
Earnings per share (Unadj.) Rs0.233.9 0.4%  
Cash flow per share (Unadj.) Rs6.640.6 16.3%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Dividend yield (eoy) %00.2 0.0%  
Book value per share (Unadj.) Rs128.8120.6 106.8%  
Shares outstanding (eoy) m31.66585.17 5.4%   
Bonus/Rights/Conversions FCCBPREF-  
Price / Sales ratio x0.64.5 13.2%   
Avg P/E ratio x516.131.3 1,647.2%  
P/CF ratio (eoy) x11.826.2 45.3%  
Price / Book Value ratio x0.68.8 6.9%  
Dividend payout %07.4 0.0%   
Avg Mkt Cap Rs m2,477621,041 0.4%   
No. of employees `000NA13.3 0.0%   
Total wages/salary Rs m5615,508 0.4%   
Avg. sales/employee Rs ThNM10,457.6-  
Avg. wages/employee Rs ThNM1,167.1-  
Avg. net profit/employee Rs ThNM1,491.6-  
INCOME DATA
Net Sales Rs m4,211138,961 3.0%  
Other income Rs m791,663 4.7%   
Total revenues Rs m4,289140,624 3.1%   
Gross profit Rs m56932,056 1.8%  
Depreciation Rs m2043,926 5.2%   
Interest Rs m4302,568 16.8%   
Profit before tax Rs m1327,225 0.0%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m67,444 0.1%   
Profit after tax Rs m519,820 0.0%  
Gross profit margin %13.523.1 58.5%  
Effective tax rate %48.027.3 175.7%   
Net profit margin %0.114.3 0.8%  
BALANCE SHEET DATA
Current assets Rs m6,852100,015 6.9%   
Current liabilities Rs m6,71174,759 9.0%   
Net working cap to sales %3.318.2 18.4%  
Current ratio x1.01.3 76.3%  
Inventory Days Days161107 149.8%  
Debtors Days Days318110 290.6%  
Net fixed assets Rs m3,67352,350 7.0%   
Share capital Rs m317585 54.1%   
"Free" reserves Rs m3,76167,707 5.6%   
Net worth Rs m4,07870,567 5.8%   
Long term debt Rs m1,6718,472 19.7%   
Total assets Rs m12,633156,994 8.0%  
Interest coverage x1.011.6 8.9%   
Debt to equity ratio x0.40.1 341.3%  
Sales to assets ratio x0.30.9 37.7%   
Return on assets %3.414.3 24.1%  
Return on equity %0.128.1 0.4%  
Return on capital %7.737.7 20.3%  
Exports to sales %22.951.0 44.9%   
Imports to sales %14.318.8 75.8%   
Exports (fob) Rs m96470,927 1.4%   
Imports (cif) Rs m60226,193 2.3%   
Fx inflow Rs m96471,015 1.4%   
Fx outflow Rs m60728,799 2.1%   
Net fx Rs m35742,216 0.8%   
CASH FLOW
From Operations Rs m1,34517,596 7.6%  
From Investments Rs m-2,256-13,801 16.3%  
From Financial Activity Rs m-1,200-198 605.0%  
Net Cashflow Rs m-2,1113,597 -58.7%  

Share Holding

Indian Promoters % 4.5 54.1 8.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 8.0 -  
FIIs % 1.4 27.7 4.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 10.2 922.5%  
Shareholders   20,807 69,601 29.9%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   DR. REDDYS LAB  IPCA LABS  ASTRAZENECA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; Pharma Sector Up 2.4%(11:30 am)

Stock markets in India are presently trading near the dotted line with positive bias. Sectoral indices are trading on a mixed note with stocks in the healthcare sector.

Related Views on News

Securities & Intelligence Services Ltd. (IPO)

Jul 31, 2017

Should you subscribe to the IPO of Securities & Intelligence Services Ltd?

Why Super Investors are Underperforming in This Market (The 5 Minute Wrapup)

Jul 8, 2017

If Super Investors can wait for the right pitch, so can you.

Tejas Networks Ltd. (IPO)

Jun 14, 2017

Should you subscribe to the IPO of Tejas Networks Ltd?

Discover the Secrets of Hidden Smallcaps From These AGMs (The 5 Minute Wrapup)

May 26, 2017

Don't be surprised to come across some Super Investors there!

A Trader's Nightmare. A Business Owner's Delight. (The 5 Minute Wrapup)

May 19, 2017

Not all small-cap investors see themselves as traders. Some see themselves as business owners.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS